ALNY
Alnylam Pharmaceuticals Inc
Price:  
157.30 
USD
Volume:  
777,663.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Alnylam WACC - Weighted Average Cost of Capital

The WACC of Alnylam Pharmaceuticals Inc (ALNY) is 8.3%.

The Cost of Equity of Alnylam Pharmaceuticals Inc (ALNY) is 8.40%.
The Cost of Debt of Alnylam Pharmaceuticals Inc (ALNY) is 7.00%.

Range Selected
Cost of equity 7.40% - 9.40% 8.40%
Tax rate 0.20% - 0.30% 0.25%
Cost of debt 7.00% - 7.00% 7.00%
WACC 7.4% - 9.3% 8.3%
WACC

Alnylam WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.76 0.81
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.40% 9.40%
Tax rate 0.20% 0.30%
Debt/Equity ratio 0.05 0.05
Cost of debt 7.00% 7.00%
After-tax WACC 7.4% 9.3%
Selected WACC 8.3%